908 Devices
908 Devices
Repligen’s $70M Deal Boosts Bioprocessing Tech!
BIOT
Repligen acquires 908 Devices' bioprocessing analytics for $70M! 💰📊 Enhancing PAT offerings and manufacturing efficiency! 🤝🔍 Biotech Innovation
Revolutionizing Bioprocessing: Faster Easier Cost-efficient Analysis
BIOT
🔍 Bioprocessing analytics tools are complex, but developers aim to make them accessible for bioprocess scientists. 🧪💰 908 Devices' Rebel device cuts analysis time from weeks to 12 minutes. ⏱️💉 Industry collaboration and regulatory support drive biomanufacturing innovation.
